Background: Broad-spectrum mineral sunscreens have assisted in correction of pigmentary disorders. A vitamin C moisturizer (VCM) containing 30% tetrahexyldecyl (THD) ascorbate clinically demonstrated improvement in patients with mild to moderate wrinkles and hyperpigmentation in a standalone study. A dual regimen treatment containing a 100% mineral TMS and a VCM, may offer further benefits in patients concerned with their hyperpigmented and photodamaged facial skin. Study design: MatTek EpiDerm tissues topically treated with 100% mineral TMS, exposed to UVB (300 mJ/cm2) 24 hours posttreatment, and incubated for an additional 24 hours, were analyzed by ELISA for CPD formation, 8-OHdG content, and H2A.X phosphorylation (n = 3). In a multicenter, open-label study, 36 female subjects (35-60 years) with moderate to severe facial hyperpigmentation and moderate global face photodamage were recruited to assess the efficacy and tolerability of a skincare regimen containing VCM and 100% mineral TMS over 12 weeks. Clinical grading using a modified Griffith 10-point scale for hyperpigmentation, overall photodamage, and skin tone evenness were performed at baseline, weeks 4, 8, and 12. Results: The 100% mineral TMS repaired UVB induced DNA damage, including CPD formation by 85% (P < .05). When paired together, the VCM and 100% mineral TMS improved hyperpigmentation and photodamaged facial skin in patients across three clinical sites compared with baseline (P < .05). Conclusion: In vitro results coupled with in vivo results strongly suggest that the dual regimen containing 100% mineral TMS paired with the VCM was strongly effective and tolerable in improving hyperpigmented and photodamaged skin.